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Conclusions: In our experimental conditions, the capability to induce
chondrogenic differentiation depends on the culture conditions used. The
transcription factor that actuates better in normoxic condition differs from
the one that displays a better action in a hypoxic atmosphere.
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GENE EXPRESSION CHANGES ASSOCIATEDWITH CHONDROGENIC
DIFFERENTIATION OF HUMANMSCS
J.F. Welter, L.A. Solchaga, K.J. Penick, P. Leahy, A.I. Caplan, V.M. Goldberg
Case Western Reserve Univ., Cleveland, OH
Purpose: Human mesenchymal stem cells (hMSCs) are useful for cartilage
tissue engineering as they can differentiate into chondrocyte-like cells
under conditions including high cell density and a deﬁned medium. Carti-
lage markers become detectable at the RNA and protein levels within the
ﬁrst week of differentiation. The phenotypic changes are the result of a
reprogramming of the gene expression and physiology of MSCs. To support
our studies of chondrogenic MSC differentiation, we used gene expression
microarrays to understand the sequence and extent of these changes.
Methods: Five hMSC preparations were derived from bone marrow aspi-
rates obtained under an IRB-approved protocol. The cells were expanded
through the end of ﬁrst passage in DMEM with serum and 10 ng/ml
FGF-2, then moved to aggregate culture in chondrogenic medium to
induce differentiation. Total RNA was extracted from 20 aggregates per
prep at days 0, 1, 3, 5, and 7; 5-8 μg of RNA were reverse-transcribed.
The three best cDNA preps were analyzed using Affymetrix U133A 2.0
microarrays. Spiked bacterial IVT were used as hybridization controls. Raw
data generated using GCOS software were scaled to 500 and imported into
Agilent GeneSpring 6.4. A short list of interesting genes was generated
by binary comparisons at each time point using MAS5.0 algorithms in
GCOS. Transcripts consistently called as increased or decreased in all three
preparations with an average absolute fold change ≥ 2.0 were included.
For genes referenced by multiple probesets, consistency checks were per-
formed, and we used the median value of the probesets. Filtered data were
then analyzed using GeneSpring, Ariadne Genomics Pathway Studio and
Partek Genomics Suite. Cluster analysis and principal component analysis
were performed on the ﬁltered data. A 3 × 3 array of self-organizing maps
(SOM) was created, and regulation pattern detection was performed; ﬁnally
assignment to speciﬁc cellular pathways attempted. We also mined the
database for chondrogenesis-related genes known to be modulated during
MSC differentiation from our experiments or from published reports.
Results: All arrays passed internal quality control. After ﬁltering the data,
we found a high-value population of 3,285 differentially expressed genes.
Cluster and SOM analysis revealed that most of the changes occurred be-
tween days 0 and 1 (1,723) or 2, with fewer changes occurring later. Small
subsets spiked or plummeted transiently on day one, even smaller subsets
showed steady in- or decreases over the study period. Pathway assignment
performed on the SOM groups suggests that genes regulating transcription,
cell-cycle, cell adhesion, and differentiation are highly regulated (both up
and down) beginning at the earliest time points.
Conclusions: We have a stringent database of gene expression changes
during early chondrogenic differentiation of hMSCs. Pattern analyses in-
dicate that most changes occur within the ﬁrst day and are permanent;
this suggests genes turned on or off during differentiation that are, thus,
MSC- or chondrocyte-speciﬁc. A much smaller set was transient, suggesting
involvement in gene expression regulation and lineage commitment. The
number of regulated genes affecting transcription, cell-cycle, cell adhesion,
and differentiation reﬂects the signiﬁcant reprogramming of the cells in the
transition from proliferation to differentiation. The database will be a use-
ful tool for interpreting molecular changes associated with chondrogenic
differentiation of MSCs.
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EFFECT OF FIBRONECTIN SPLICING ON CELL PROLIFERATION AND
CHONDROCYTE-SPECIFIC GENE EXPRESSION IN A MESENCHYMAL STEM
CELL SYSTEM
S.A. Jami, N.B. Sepulveda, J.H. Peters
UC Davis, Sacramento, CA
Purpose: During embryonic development, expression of ﬁbronectins (FNs)
bearing the alternatively spliced EIIIA and V segments is prevalent in
prechondrogenic mesenchymal cell condensations. However, expression of
these FNs becomes restricted near the time of chondrogenesis, suggesting
that they may not be compatible with processes by which mesenchymal
stem cells (MSCs) differentiate to chondrocytes.
Methods: We tested the effects of the EIIIA and V segments, expressed as
glutathione S-transferase (GST) fusion proteins, adsorbed to plastic or in
solution, on proliferation and gene expression in rat RCJ 3.1 multipotential
mesenchymal cells, an MSC model cell line, using 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and real-time PCR. A
GST fusion protein containing the 10th type III repeat of FN (III-10) and
poly-L-lysine (PLL) were also tested.
Results: In 15% fetal bovine serum (FBS), cells grown in monolayer for 7
days (d) on surfaces coated with EIIIA, V, III-10, or PLL appeared conﬂuent,
and attained similar MTT scores, with OD570-630 values (average±S.D.)
of 1.3±0.8, 1.4±0.8, 1.3±0.7, and 1.5±1.0, respectively (ns, N=3). Under
serum-free conditions, more cells remained adherent to surfaces coated
with III-10 than the other 3 agents after 7 d in HEScGRO (Millipore),
with respective values of 0.2±0.1**, 0.2±0.1**, 0.6±0.2, and 0.4±0.2*. In
KnockoutSR (GIBCO), V and III-10 both promoted greater retention of
adherent cells than EIIIA and PLL, with respective values for the 4 agents
of 0.2±0.0***, 0.6±0.1, 0.7±0.1, and 0.3±0.1**. Aggrecan expression in cells
grown in 15% FBS for 7 d on each of the substrates decreased compared
to cells grown for 1 d on III-10, but not signiﬁcantly so (fold changes of
-1.0±0.7, -0.7±0.6, -2.8±0.1, and -2.6±0.3, respectively) (N=3). In contrast,
aggrecan expression increased in cells grown in pellet culture in the pres-
ence of TGF-b, with a fold change of 2.5±1.0 at 14 d compared to cells at
0 d (ns, N=3). Addition of soluble EIIIA (200 nM) to such cultures triggered
reduced aggrecan expression so that the fold change at 14 d compared to 0
d cells was -7.1±0.1 (18.6-fold reduction compared to untreated cells, ***,
N=3). p>0.05=ns, p<0.05=* o<0.01=***, p<0.001=***
Conclusions: The 10th type III repeat and V segment of FN promote
anchorage-dependent proliferation/survival of RCJ 3.1 MSCs in serum-free
culture. These cells lose aggrecan expression in monolayer culture, and this
is not appreciably affected by apposition to EIIIA, V, or III-10. In contrast,
aggrecan expression increases during pellet culture, and such acquisition of
chondrocyte-speciﬁc gene expression is inhibited by soluble EIIIA, suggest-
ing that this FN segment could potentially constitute a therapeutic target
in efforts to promote chondrocytic differentiation of MSCs, or to reverse
cartilage degeneration in osteoarthritis. Research funded by a VA Merit
grant.
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SEQUENTIALLY PROGRAMMEDMAGNETIC FIELD THERAPY AS AN
EFFECTIVE TREATMENT FOR OSTEOARTHRITIS
V.G. Vasishta Sr.
Former Prof and HOD, Inst. of Aerospace Med., Indian Air Force, Bangalore,
India
Introduction and Purpose: Different modalities of available treatment for
treating osteoarthritis, including newer drugs like NSAIDS, Intra-articular
injections, etc have been tried with very little or no success, leaving
patients with the only surgical option of joint replacement. All of these
except surgery provide only symptomatic relief and do not reverse the
continuous damage done to the cartilage. The newer drugs also come
withmany undesirable side effects. Total knee replacement Surgery (TKR) is
often beyond the ﬁnancial reach of many patients, especially in developing
countries. Even TKR surgery has a severe painful recovery period and a low
patient acceptance. So there has always been a need for a safe treatment
method which would be pain free and also reverse the disease process.
Sequentially Programmed Magnetic Field (SPMF) Therapy utilizes Magnetic
Field Generators (MFG) that can be precisely controlled and focused onto
the affected tissues. The normal physiological remodeling of cartilage oc-
curs due to piezoelectric stimuli which are lost in osteoarthritic patients.
